Molecular Classification of Central Nervous System Tumors in Developing Countries: Challenges, Opportunities, and Feasibility in a Pathology Reference Laboratory.

IF 3.2
Igor Lima Fernandes, Zied Abdullaev, Martha Quezado, Kenneth Aldape, Carlos E Bacchi
{"title":"Molecular Classification of Central Nervous System Tumors in Developing Countries: Challenges, Opportunities, and Feasibility in a Pathology Reference Laboratory.","authors":"Igor Lima Fernandes, Zied Abdullaev, Martha Quezado, Kenneth Aldape, Carlos E Bacchi","doi":"10.5858/arpa.2025-0272-OA","DOIUrl":null,"url":null,"abstract":"<p><strong>Context.—: </strong>In the past decade, central nervous system (CNS) tumor diagnosis has shifted toward molecular classification. Tools like DNA/RNA sequencing and methylation array analysis are now supportive tools, as reflected in the World Health Organization Classification of Tumours of the Central Nervous System, 5th edition. However, implementing these sophisticated and costly methods remains challenging for health care services in most developing countries.</p><p><strong>Objective.—: </strong>To report the implementation and utility of methylation array-based classification in CNS tumor cases at a Brazilian pathology reference laboratory, and to explore practical challenges and opportunities for achieving diagnostic precision in resource-constrained environments.</p><p><strong>Design.—: </strong>This study analyzed 319 CNS tumor cases that underwent methylation analysis. Cases were stratified into 6 categories: (1) Methylation Confirms or Narrows Initial Diagnosis; (2) Diagnosis Modified by Methylation; (3) Diagnosis Confirmed With Molecular Subclassification; (4) Specification of Initially Descriptive Diagnosis; (5) Emerging Entities; and (6) Unclassified/Inconclusive. We analyzed diagnostic impact, costs, and turnaround time.</p><p><strong>Results.—: </strong>DNA methylation profiling was successfully completed in most cases, with preanalytical failures mainly due to insufficient DNA quantity or quality. Turnaround time varied with regional logistics. Classifier outputs yielded confident matches for most cases. However, 47 cases (14.7% of cohort) produced \"no match\" results due to low confidence scores (≤0.30) or divergent classifier outputs. Additional testing was performed when available.</p><p><strong>Conclusions.—: </strong>DNA methylation profiling improves diagnostic accuracy and reclassifies a meaningful proportion of brain tumor cases. Broad implementation requires evidence of cost-effectiveness, streamlined workflows, and capacity building, particularly in low- and middle-income settings.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"548-558"},"PeriodicalIF":3.2000,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of pathology & laboratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5858/arpa.2025-0272-OA","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Context.—: In the past decade, central nervous system (CNS) tumor diagnosis has shifted toward molecular classification. Tools like DNA/RNA sequencing and methylation array analysis are now supportive tools, as reflected in the World Health Organization Classification of Tumours of the Central Nervous System, 5th edition. However, implementing these sophisticated and costly methods remains challenging for health care services in most developing countries.

Objective.—: To report the implementation and utility of methylation array-based classification in CNS tumor cases at a Brazilian pathology reference laboratory, and to explore practical challenges and opportunities for achieving diagnostic precision in resource-constrained environments.

Design.—: This study analyzed 319 CNS tumor cases that underwent methylation analysis. Cases were stratified into 6 categories: (1) Methylation Confirms or Narrows Initial Diagnosis; (2) Diagnosis Modified by Methylation; (3) Diagnosis Confirmed With Molecular Subclassification; (4) Specification of Initially Descriptive Diagnosis; (5) Emerging Entities; and (6) Unclassified/Inconclusive. We analyzed diagnostic impact, costs, and turnaround time.

Results.—: DNA methylation profiling was successfully completed in most cases, with preanalytical failures mainly due to insufficient DNA quantity or quality. Turnaround time varied with regional logistics. Classifier outputs yielded confident matches for most cases. However, 47 cases (14.7% of cohort) produced "no match" results due to low confidence scores (≤0.30) or divergent classifier outputs. Additional testing was performed when available.

Conclusions.—: DNA methylation profiling improves diagnostic accuracy and reclassifies a meaningful proportion of brain tumor cases. Broad implementation requires evidence of cost-effectiveness, streamlined workflows, and capacity building, particularly in low- and middle-income settings.

发展中国家中枢神经系统肿瘤的分子分类:病理参考实验室的挑战、机遇和可行性。
上下文。-:在过去的十年中,中枢神经系统(CNS)肿瘤的诊断已经转向分子分类。正如世界卫生组织《中枢神经系统肿瘤分类》第5版所反映的那样,DNA/RNA测序和甲基化阵列分析等工具现在是支持性工具。然而,在大多数发展中国家,实施这些复杂而昂贵的方法对卫生保健服务仍然具有挑战性。-:报告巴西病理参考实验室在中枢神经系统肿瘤病例中甲基化阵列分类的实施和应用,并探讨在资源受限的环境中实现精确诊断的实际挑战和机遇。-:本研究对319例中枢神经系统肿瘤病例进行了甲基化分析。病例分为6类:(1)甲基化证实或缩小了初始诊断;(2)甲基化修饰诊断;(3)分子亚分类确诊;(4)初步描述性诊断说明;(5)新兴主体;(6)未分类/不确定。我们分析了诊断影响、成本和周转时间。-: DNA甲基化分析在大多数情况下成功完成,分析前失败主要是由于DNA数量或质量不足。周转时间因地区物流而异。分类器输出在大多数情况下产生了可靠的匹配。然而,47例(占队列的14.7%)由于置信度评分低(≤0.30)或分类器输出不同而产生“不匹配”结果。在可能的情况下进行了额外的测试。-: DNA甲基化分析提高了诊断准确性,并对脑肿瘤病例进行了有意义的重新分类。广泛实施需要成本效益的证据、简化的工作流程和能力建设,特别是在低收入和中等收入环境中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书